Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast.
about
Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RXDoxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
P2860
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Mitoriboscins: Mitochondrial-b ...... bacteria and pathogenic yeast.
@en
type
label
Mitoriboscins: Mitochondrial-b ...... bacteria and pathogenic yeast.
@en
prefLabel
Mitoriboscins: Mitochondrial-b ...... bacteria and pathogenic yeast.
@en
P2093
P2860
P50
P356
P1154
2-s2.0-85030172885
P1433
P1476
Mitoriboscins: Mitochondrial-b ...... bacteria and pathogenic yeast.
@en
P2093
Anna Rita Cappello
Bela Ozsvari
Gloria Bonuccelli
Luca Frattaruolo
Marco Fiorillo
Rachel Trowbridge
P2860
P304
67457-67472
P356
10.18632/ONCOTARGET.19084
P407
P5530
P577
2017-07-07T00:00:00Z
P6179
1090576021